Analyst Reco. CareDx, Inc

Equities

CDNA

US14167L1035

Market Closed - Nasdaq Other stock markets 21:00:00 01/05/2024 BST			5-day change	1st Jan Change
9.18 ^USD	+18.30%		+15.04%	-23.50%

04-16	CareDx Appoints John Hanna as CEO, President	MT
04-16	CareDx, Inc Appoints John W. Hanna as Chief Executive Officer	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Stephens Upgrades CareDx to Overweight From Equalweight, Price Target is $10	11-09	MT
Raymond James Upgrades CareDx to Outperform From Market Perform, Price Target is $12	15/08/23	MT
BTIG Research Downgrades CareDx to Neutral From Buy	11/05/23	MT
Goldman Sachs Lowers Price Target on CareDx to $13 From $25, Maintains Buy Rating	07/03/23	MT
Stephens Downgrades CareDx to Equalweight From Overweight, Adjusts Price Target to $9 From $19	07/03/23	MT
Craig-Hallum Downgrades CareDx to Hold From Buy, Adjusts Price Target to $9 From $26	03/03/23	MT
Raymond James Downgrades CareDx to Market Perform From Strong Buy, $24 Price Target	03/03/23	MT
Craig-Hallum Adjusts CareDx's Price Target to $26 From $32, Keeps Buy Rating	28/02/23	MT
BTIG Adjusts Price Target on CareDx to $25 From $28, Maintains Buy Rating	28/02/23	MT
Goldman Sachs Adjusts CareDx's Price Target to $25 From $29, Maintains Buy Rating	28/02/23	MT
Goldman Sachs Adjusts Price Target on CareDx to $29 From $40, Maintains Buy Rating	06/02/23	MT
Raymond James Adjusts CareDx's Price Target to $24 From $26, Maintains Strong Buy Rating	31/01/23	MT
BTIG Adjusts Price Target on CareDx to $28 From $37, Maintains Buy Rating	07/11/22	MT
Raymond James Adjusts Price Target on CareDx to $35 From $45, Reiterates Strong Buy Rating	10/08/22	MT
Goldman Sachs Adjusts Price Target for CareDx to $45 From $50, Maintains Buy Rating	18/07/22	MT
Stephens Initiates CareDx at Overweight with $50 Price Target	25/04/22	MT
Raymond James Adjusts CareDx's Price Target to $52 from $90, Maintains Strong Buy Rating	25/02/22	MT
Raymond James Adjusts CareDx PT to $90 From $108, Maintains Strong Buy Rating	29/10/21	MT
CAREDX : Piper Sandler Adjusts Price Target on CareDx to $110 From $100, Reiterates Overweight Rating	30/07/21	MT
CAREDX : BTIG Analyst Assumes Coverage on CareDx at Buy, Sets $115 Price Target	20/07/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. CareDx, Inc

Equities

CDNA

US14167L1035

Analyst Reco.

Filters